This animal model study corroborates the observations in humans, indicating that COVID-19 can induce an increase in the number and activity of monocytes in the peripheral tissues, and these effects can be attenuated by inhibiting the IL-6 pathway (17). The gene discussed is IL6; the disease is COVID-19.